Scarica l'app Stockscreener
2.41
7.02%
0.13
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Atossa Therapeutics Inc Borsa (ATOS) Ultime notizie
Rodman & Renshaw initiates Atossa Genetics stock with buy rating By Investing.com - Investing.com Canada
ATOSAtossa Therapeutics Inc Short Interest - Finviz
ATOS Stock Drops After Hours On Earnings Miss — CEO Now Bets On New Uses For Its Experimental Cancer Drug - Stocktwits
Atossa Therapeutics, Inc.(NasdaqCM:ATOS) added to Russell Microcap Value Benchmark Index - marketscreener.com
Atossa Therapeutics, Inc.(NasdaqCM: ATOS) added to Russell 3000E Index - marketscreener.com
Price to book forward of Atossa Therapeutics, Inc. – NASDAQ:ATOS - TradingView
Atossa Therapeutics, Inc.(NasdaqCM: ATOS) added to Russell Microcap Index - marketscreener.com
Atossa Therapeutics, Inc.(NasdaqCM: ATOS) added to Russell 3000E Growth Benchmark - marketscreener.com
Atossa Therapeutics, Inc.(NasdaqCM: ATOS) added to Russell 3000E Value Benchmark - marketscreener.com
Atossa Therapeutics, Inc. adopts integrated biologic signals to advance breast cancer research - Traders Union
Price to sales forward of Atossa Therapeutics, Inc. – MUN:YAG - TradingView
Price to book forward of Atossa Therapeutics, Inc. – MUN:YAG - TradingView
Price to earnings forward of Atossa Therapeutics, Inc. – MUN:YAG - TradingView
Enterprise value to EBITDA forward of Atossa Therapeutics, Inc. – MUN:YAG - TradingView
ATOS Should I Buy - Intellectia AI
Atossa Therapeutics, Inc. (NASDAQ:ATOS): Are Analysts Optimistic? - simplywall.st
Atossa Therapeutics Inc (ATOS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Atossa Therapeutics raises $4.5M in registered direct offering By Investing.com - Investing.com Nigeria
Atossa Therapeutics Inc (ATOS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Atossa Therapeutics Inc (ATOS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Atossa Therapeutics Inc (ATOS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Atossa Therapeutics Inc (ATOS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Atossa Therapeutics Inc (ATOS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Atossa Therapeutics Inc (ATOS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Atossa Therapeutics Inc (ATOS) Institutional Confidence - TradingKey
Atossa Therapeutics Inc (ATOS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Atossa Therapeutics brings medical innovation to Hudson Institute strategic discussions - Traders Union
Atossa Therapeutics (ATOS) Q1 2026 Earnings: Narrowing Losses with Positive EPS SurpriseRevenue Warning Signal - newsline.com
Atossa Therapeutics closes $4.5M registered direct offering By Investing.com - Investing.com Australia
Atossa Therapeutics closes $4.5M registered direct offering - Investing.com
Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds - PR Newswire
Atossa Therapeutics Announces Up To $16.5 Million Registered Direct Offering - Pulse 2.0
Atossa Therapeutics examines biosecurity and scientific innovation after COVID 19 lessons - Traders Union
Atossa Therapeutics (NASDAQ: ATOS) sells 1.36M shares with warrants in $4.5M deal - Stock Titan
Market Movers | Winners: XXII, PPCB, CCHH | Losers: BCPC, ATOS, BATL - Trefis
Atossa Therapeutics, Inc. (ATOS) Latest Stock News & Headlines - Yahoo Finance
Top Midday Decliners - Moomoo
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Crude Oil Edges Higher; Driven Brands Posts Upbeat Earnings - Benzinga
Dow Jumps Over 250 Points; US Initial Jobless Claims RiseAtossa Therapeutics (NASDAQ:ATOS), Big Tree C - Benzinga
Atossa Therapeutics Launches $16.5 Million Registered Direct Offering - marketscreener.com
Atossa Therapeutics stock tumbles on $4.5M stock offering - Investing.com UK
Atossa Therapeutics Announces Registered Direct Offering and Warrants - TipRanks
Atossa Therapeutics stock tumbles on $4.5M stock offering By Investing.com - Investing.com Nigeria
Atossa Therapeutics raises $4.5M in registered direct offering - Investing.com
12 Health Care Stocks Moving In Thursday's Pre-Market SessionAditxt (NASDAQ:ADTX), Atossa Therapeutics - Benzinga
Atossa Therapeutics Prices Registered Direct Offering at $3.30, Netting About $4.1 Million - TradingView
Atossa Therapeutics (ATOS) prices $3.30 registered direct stock and warrant sale - Stock Titan
Atossa Therapeutics Announces Registered Direct Offering of up to $16.5 Million in Gross Proceeds - PR Newswire
Atossa Therapeutics highlights Endoxifen progress as potential Breast Cancer treatment - Proactive financial news
1.83%
3.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):